We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers at Salk Institute for Biological Studies ...
Microbiota-reactive T cells trigger colitis in mice harboring the microbiota of wild-caught mice following CTLA-4 blockade, according to a new study that reveals a major mechanism by which anti-CTLA-4 ...
DelveInsight's CTLA-4 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, emerging CTLA-4 inhibitors, market share of individual therapies, and ...
Microbiota-reactive T cells trigger colitis in mice harboring the microbiota of wild-caught mice following CTLA-4 blockade, according to a new study that reveals a major mechanism by which anti-CTLA-4 ...
Checkpoint inhibitors act as a double-edged sword against cancer. Although they promote potent antitumor responses, they can also cause several adverse effects. This article joins a growing series on ...
PRESERVE-003 is evaluating gotistobart vs. docetaxel in patients with squamous non-small cell lung cancer (sqNSCLC) who have progressed on chemotherapy and immune checkpoint therapies Pivotal Stage II ...
MSI-H/dMMR colon cancer accounts for around 15% of all resectable colon cancer cases [ii]. Due to its unique biological characteristics, this class of tumor shows limited sensitivity to chemotherapy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback